Clinical Trial: Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder and Insomnia

U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07555743) titled 'Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder and Insomnia' on April 09.

Brief Summary: The goal of this clinical trial is to evaluate the efficacy and safety of Daridorexant in major depressive disorder (MDD) patients with comorbid insomnia. The main questions to answer are:

1. Does Daridorexant improve the severity of insomnia as measured by the Insomnia Severity Index (ISI)?

2. Does Daridorexant have an impact on depressive symptoms?

In order to address these questions, researchers will compare Daridorexant with a placebo to evaluate its impact on both insomnia and MDD-related symptoms.

Parti...